Cogent Biosciences
17 open jobs
Senior Director, Global Market Access
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Senior Director, Global Market Access at Cogent Biosciences seen live 2 days ago posted 6 days agoScientist, DMPK (BioAnalytical and Medical Writing)
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Scientist, DMPK (BioAnalytical and Medical Writing) at Cogent Biosciences seen live 2 days ago posted 7 days agoDirector, National Payer Accounts
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Director, National Payer Accounts at Cogent Biosciences seen live 2 days ago posted 13 days agoDirector, Patient Advocacy & Engagement
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Director, Patient Advocacy & Engagement at Cogent Biosciences seen live 2 days ago posted 14 days agoManager, Communications and Investor Relations
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Manager, Communications and Investor Relations at Cogent Biosciences seen live 2 days ago posted 19 days agoAssociate Director, Translational Medicine
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Associate Director, Translational Medicine at Cogent Biosciences seen live 2 days ago posted 21 days agoDirector, Corporate Counsel
Who We Are: Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the
Contracts Specialist
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Associate Director, Analytical Development
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Associate Director, Analytical Development at Cogent Biosciences seen live 2 days ago posted 67 days agoAssociate Director, Clinical Operations
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Associate Director, Clinical Operations at Cogent Biosciences seen live 2 days ago posted 76 days agoDirector, Drug Substance Manufacturing & Development
Who We Are: Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the
Applyto Director, Drug Substance Manufacturing & Development at Cogent Biosciences seen live 2 days ago posted 81 days agoAssociate Director, Patient Marketing
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Associate Director, Patient Marketing at Cogent Biosciences seen live 2 days ago posted 101 days agoSenior Medical Science Liaison - Midwest (Detroit, Minneapolis, Central Plains)
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Senior Medical Science Liaison - Midwest (Detroit, Minneapolis, Central Plains) at Cogent Biosciences seen live 2 days ago posted 111 days agoPrincipal Scientist, Computational Chemistry
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Principal Scientist, Computational Chemistry at Cogent Biosciences seen live 2 days ago posted 172 days agoAssociate Director, Trade Operations
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Associate Director, Trade Operations at Cogent Biosciences seen live 2 days ago posted 194 days agoSenior Medical Science Liaison - West Region (Los Angeles, San Diego, Las Vegas, Mountain States {Idaho, Utah, Montana, Wyoming})
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Senior Medical Science Liaison - West Region (Los Angeles, San Diego, Las Vegas, Mountain States {Idaho, Utah, Montana, Wyoming}) at Cogent Biosciences seen live 2 days ago posted 196 days agoResearch Investigator, Computational Chemistry
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17
Applyto Research Investigator, Computational Chemistry at Cogent Biosciences seen live 2 days ago posted 229 days ago